Nyval av två ledamöter, Uli Hacksell och Lennart Hansson. Som vd för ACADIA Pharmaceuticals ledde Hacksell utvecklingen från privat start-up företag till

View Uli Hacksell's profile on LinkedIn, the world's largest professional community. Uli has 1 job EVP & Chief Commercial Officer, ACADIA Pharmaceuticals.

ACADIA Pharmaceuticals Inc. uses 4 email formats: 1. first_initial ACADIA Pharmaceuticals Inc.'s Email Format, Percentage Uli Hacksell's profile photo. I, Uli Hacksell, Ph.D., certify that: 1. I have reviewed this annual report on Form 10 -K for the year ended December 31, 2006 of ACADIA Pharmaceuticals Inc. 2. Acadia Pharmaceuticals (NASDAQ:ACAD) stock surged 155 per cent Tuesday successfully met all the objectives of this study," Acadia CEO Uli Hacksell said.

Uli hacksell acadia pharmaceuticals

Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships. Acadia Pharmaceuticals Inc. 10/2000–03/2015. Chairman. Action ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Steve Davis Appointed Interim Chief Executive Officer March 11, 2015 04:02 PM Eastern Daylight Time Uli Hacksell – Chief Executive Officer Stephen R. Davis – Executive Vice President, Chief Financial Officer & Chief Business Officer Roger G. Mills – Executive Vice President, Development & Chief In 2001, the company's chief executive officer at the time, Leonard R. Borrmann, left Acadia to lead Maret Pharmaceuticals. He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2014 Results Earnings Conference Call May 6, 2014 5:00 PM ET Executives.

Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag.

ACADIA Pharmaceuticals has an analyst consensus of Strong Buy, with a price He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the

Som vd för ACADIA Pharmaceuticals 2000–2015 ledde Uli Hacksell utvecklingen från privat start-up företag till ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Titles of the Plans) Uli Hacksell, Ph.D. President and Chief Executive Officer .

Affiliation. 1 ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA, uli@acadia-pharm.com. PMID: 24682754; PMCID:

President and Chief Executive Officer . ACADIA Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871 ULI HACKSELL is Chief Executive Officer and Director of ACADIA Pharmaceuticals Inc. He joined ACADIA as Executive Vice President of Drug Discovery in February 1999 and was elected Chief Executive Uli Hacksell is a party in the following contracts and agreements covering employment salaries, health care benefits, board directorships and more. Contracts. Acadia Pharmaceuticals Inc – ACADIA PHARMACEUTICALS INC. EXECUTIVE EMPLOYMENT TRANSITION AGREEMENT (May 7th, 2015) The estimated Net Worth of Uli Hacksell is at least 61 千$ dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over 61,000$ and over the last 17 years Uli sold CERC stock worth over 0$.Cerecor Inc stock worth over 61,000$ and over the last 17 years Uli … The estimated Net Worth of Uli Hacksell is at least $59.6 millier dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0. Uli Hacksell has over 20 years of international management experience from both large pharmaceutical and biotech companies.

13 Nov 2017 Beactica, a Swedish drug discovery company, announced the financing round and the appointments of Erik Walldén and Uli Hacksell to its board, at two NASDAQ-listed companies: Cerecor and ACADIA Pharmaceuticals. 9 Jul 2015 He was the CEO of ACADIA Pharmaceuticals from September 2000 to March 2015, and led the company from a private start-up to becoming a Acadia Pharmaceuticals CEO Uli Hacksell speaks at the Jefferies 2013 Global Healthcare Conference in New York, June 5, 2013.
Delselius konditori gustavsberg

Som vd för ACADIA Pharmaceuticals 2000–2015 ledde Uli Hacksell utvecklingen från privat start-up företag till ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN.

Styrelseledamot sedan 2019. Född View the profiles of professionals named "Hacksell" on LinkedIn. There are 30+ Uli Hacksell. San Diego, CA · Uli Hacksell.
Svetruck 25120

boskolans friskola
essity aktiebolag stock
arne imsen
seb bank new york
vilket block tillhör vänsterpartiet
sundbyholms gästhamn cafe

ACADIA Pharmaceuticals Inc. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Title of the Plan) Uli Hacksell, Ph.D. President and Chief Executive Officer . ACADIA Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871 (Telephone Number, Including Area Code, of Agent for Service)

Lisa Barthelemy - Director of Investor Relations. Uli Hacksell - Chief Executive Officer 2018-06-29 · Marina Biotech Appoints Uli Hacksell, Ph.D. and Robert C. Moscato to Board of Directors. Dr. Hacksell served as the Chief Executive Officer and as a director of ACADIA Pharmaceuticals Inc. Uli Hacksell is considered to be independent in relation to the company as well as its senior management and in relation to major shareholders.

Gymnasium estetiska programmet
sparinvest value aktier

Dr. Hacksell commented: “I look forward to working with the Glionova team and some of the most experienced investors in the Nordics to develop this ground breaking therapy”. Dr. Uli Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals from September 2000 to March 2015 and was a member of its Board of Directors.

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0. Uli Hacksell has over 20 years of international management experience from both large pharmaceutical and biotech companies. He was the CEO of ACADIA Pharmaceuticals from September 2000 to March 2015, and led the company from a private start-up to becoming a public … The estimated Net Worth of Uli Hacksell is at least $65.8 Mille dollars as of 10 December 2016.